Clinical trial
Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease…
NCT00224055 · Watson Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00224055 |
|---|---|
| Title | Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients |
| Official title | A Randomized, Controlled, Open-label Study of the Safety and Efficacy of Ferrlecit® vs Oral Iron in Iron Deficient Patients With Chronic Kidney Disease |
| Lead sponsor | Watson Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia, Iron-Deficiency, Kidney Failure, Chronic |
| Intervention type | Drug |
| Interventions | Sodium Ferric Gluconate Complex in Sucrose Injection, Ferrous sulfate tablets |
| Enrollment | 89 |
| Start date | Apr 1, 2003 |
| Primary completion | Sep 1, 2004 |
| Completion | Sep 1, 2004 |
| First posted | Sep 22, 2005 |
| Last update posted | Mar 29, 2012 |
| Countries | Puerto Rico, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: